Neutral
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm has announced an investigation into Grace Therapeutics, Inc. (NASDAQ: GRCE) on behalf of investors who may have suffered losses du...